Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Legriel, Stephane ^a   Schraub, Olivier ^a   Azoulay, Elie ^b   Hantson, Philippe ^c   Magalhaes, Eric ^d   Coquet, Isaline ^e   Bretonniere, Cedric ^f   Gilhodes, Olivier ^g   Anguel, Nadia ^h   Megarbane, Bruno ⁱ   Benayoun, Laurent ^j   Schnell, David ^b   Plantefeve, Gaetan ^k   Charpentier, Julien ^l   Argaud, Laurent ^m   Mourvillier, Bruno ⁿ   Galbois, Arnaud ^o   Chalumeau Lemoine, Ludivine ^p   Rivoal, Michel ^q   Durand, François ^j   Geffroy, Arnaud ⁿ   Simon, Marc ^r   Stoclin, Annabelle ^s   Pallot, Jean Louis ^q   Arbelot, Charlotte ^t   Nyunga, Martine ^u   Lesieur, Olivier ^v   Troché, Gilles ^a   Bruneel, Fabrice ^a   Cordoliani, Yves Sébastien ^w   Bedos, Jean Pierre ^a   Pico, Fernando ^d   more..

^a Medical Surgical Intensive Care Department   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d Neurology Department and Stroke Center   (France)

^e FOCH HOSPITAL   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^h Chu de Bicêtre   (France)

ⁱ HÔPITAL LARIBOISIÈRE   (France)

^j BEAUJON HOSPITAL   (France)

^k Medical Surgical Intensive Care Department   (France)

^l Institut Cochin   (France)

^m EDOUARD HERRIOT HOSPITAL   (France)

ⁿ BICHAT HOSPITAL   (France)

^o HÔPITAL SAINT ANTOINE   (France)

^p HÔPITAL TENON   (France)

^q Medical Surgical Intensive Care Department   (France)

^r Cliniques du Sud Luxembourg of Arlon   (Belgium)

^s INSTITUT GUSTAVE ROUSSY   (France)

^t PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^u CH de Roubaix   (France)

^v Medical Surgical Intensive Care Department   (France)

^w Hôpital Privé Parly 2   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; ANTIRETROVIRUS AGENT; BEVACIZUMAB; BORTEZOMIB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; CYTOTOXIC AGENT; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; LYSERGAMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN REGION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DISEASE ASSOCIATION; DRUG INTOXICATION; DRUG MEGADOSE; ECLAMPSIA; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL NEUROIMAGING; GLASGOW OUTCOME SCALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION ENCEPHALOPATHY; INTENSIVE CARE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL BONE; OUTCOME ASSESSMENT; PARIETAL LOBE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREECLAMPSIA; RETROSPECTIVE STUDY; SEIZURE; SYMPTOMATOLOGY; TOXEMIA; WHITE MATTER;

ADULT; BRAIN; COHORT STUDIES; FEMALE; HUMANS; LOD SCORE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 84866362665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044534     Document Type: Article

References (41)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, et al. (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494-500.
2. Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, et al. (1992) Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 159: 379-383.
3. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, et al. (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 165: 627-631.
4. Bartynski WS, (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29: 1036-1042.
5. Bartynski WS, (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29: 1043-1049.
6. Bartynski WS, Boardman JF, (2007) Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 28: 1320-1327.
7. Legriel S, Pico F, Azoulay E (2011) Understanding Posterior Reversible Encephalopathy Syndrome. In: Vincent J-L, editor. Annual Update in Intensive Care and Emergency Medicine 2011: Springer Berlin Heidelberg. 631-653.
8. Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, et al. (2010) Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg.
9. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA, (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65: 205-210.
10. Servillo G, Striano P, Striano S, Tortora F, Boccella P, et al. (2003) Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 29: 2323-2326.
11. Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA, (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69: 894-897.
12. Legriel S, Merceron S, Pico F, Cordoliani YS, Bedos JP (2011) A rare cause of status epilepticus. Intensive Care Med.
13. Legriel S, Bruneel F, Spreux-Varoquaux O, Birenbaum A, Chadenat ML, et al. (2008) Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus. Neurocrit Care 9: 247-252.
14. Teasdale G, Jennett B, (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet 2: 81-84.
15. Bateman DE, (2001) Neurological assessment of coma. J Neurol Neurosurg Psychiatry 71Suppl 1: i13-17.
16. Wippold FJ Jr, (2008) Focal neurologic deficit. AJNR Am J Neuroradiol 29: 1998-2000.
17. Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, et al. (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345: 631-637.
18. Lowenstein DH, Bleck T, Macdonald RL, (1999) It's time to revise the definition of status epilepticus. Epilepsia 40: 120-122.
19. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, et al. (2002) Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 59: 205-210.
20. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, et al. (1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 339: 792-798.
21. Treiman DM, Walton NY, Kendrick C, (1990) A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 5: 49-60.
22. Kaplan PW, (2006) The EEG of status epilepticus. J Clin Neurophysiol 23: 221-229.
23. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28: 1462-1536.
24. Legriel S, Azoulay E, Resche-Rigon M, Lemiale V, Mourvillier B, et al. (2010) Functional outcome after convulsive status epilepticus. Crit Care Med 38: 2295-2303.
25. Vaughan CJ, Delanty N, (2000) Hypertensive emergencies. Lancet 356: 411-417.
26. Le GallJR, Lemeshow S, Saulnier F, (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270: 2957-2963.
27. Le GallJR, Klar J, Lemeshow S, Saulnier F, Alberti C, et al. (1996) The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276: 802-810.
28. Jennett B, Teasdale G, Braakman R, Minderhoud J, Knill-Jones R, (1976) Predicting outcome in individual patients after severe head injury. Lancet 1: 1031-1034.
29. McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, et al. (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189: 904-912.
30. Casey SO, Sampaio RC, Michel E, Truwit CL, (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21: 1199-1206.
31. Servillo G, Bifulco F, De Robertis E, Piazza O, Striano P, et al. (2007) Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 33: 230-236.
32. Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, et al. (2009) Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology 51: 373-383.
33. Godoy DA, Di Napoli M, Rabinstein AA, (2010) Treating hyperglycemia in neurocritical patients: benefits and perils. Neurocrit Care 13: 425-438.
34. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC, (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32: 2426-2432.
35. Garg R, Chaudhuri A, Munschauer F, Dandona P, (2006) Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 37: 267-273.
36. Fogelholm R, Murros K, Rissanen A, Avikainen S, (2005) Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatry 76: 349-353.
37. Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A, (2005) The impact of hyperglycemia on patients with severe brain injury. J Trauma 58: 47-50.
38. Sala F, Menna G, Bricolo A, Young W, (1999) Role of glycemia in acute spinal cord injury. Data from a rat experimental model and clinical experience. Ann N Y Acad Sci 890: 133-154.
39. Wilson JT, Pettigrew LE, Teasdale GM, (1998) Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15: 573-585.
40. de Gans J, van de Beek D, (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347: 1549-1556.
41. Todd MM, Hindman BJ, Clarke WR, Torner JC, (2005) Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 352: 135-145.